| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 27.825 | 43.523 | 33.076 | 41.433 | 34.529 | 41.164 | 72.095 | 68.024 | 67.115 |
| Total Income - EUR | 0 | 27.825 | 43.729 | 33.226 | 41.433 | 38.118 | 41.164 | 72.095 | 68.024 | 67.137 |
| Total Expenses - EUR | 2.055 | 21.956 | 28.099 | 34.704 | 40.260 | 32.837 | 38.154 | 50.231 | 53.758 | 62.041 |
| Gross Profit/Loss - EUR | -2.055 | 5.869 | 15.630 | -1.477 | 1.173 | 5.281 | 3.010 | 21.864 | 14.266 | 5.097 |
| Net Profit/Loss - EUR | -2.055 | 5.312 | 14.909 | -1.810 | 758 | 5.053 | 2.706 | 21.237 | 13.679 | 3.374 |
| Employees | 0 | 1 | 2 | 3 | 3 | 3 | 3 | 4 | 3 | 4 |
Check the financial reports for the company - Redclinic Line Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.249 | 21.002 | 17.929 | 13.942 | 9.753 | 6.885 | 23.343 | 42.682 | 36.198 | 30.942 |
| Current Assets | 250 | 39 | 3.179 | 4.009 | 8.307 | 12.239 | 2.115 | 2.367 | 2.513 | 5.947 |
| Inventories | 0 | 0 | 0 | 0 | 39 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 1.710 | 0 | 537 | 148 |
| Cash | 250 | 39 | 3.179 | 4.009 | 8.268 | 12.239 | 405 | 2.367 | 1.976 | 5.799 |
| Shareholders Funds | -2.010 | 3.323 | 18.175 | 16.032 | 16.480 | 17.304 | 19.627 | 40.924 | 30.308 | 33.513 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 20.733 | 17.718 | 2.933 | 1.919 | 1.579 | 1.821 | 12.194 | 4.126 | 8.403 | 3.376 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Redclinic Line Srl